Sunday , May 16 2021

Covid-19 vaccine problem, epidemiologist Hariadi Vibosono: No need to worry, you must understand the benefits of vaccines



TRIBUNMANADO.CO.ID – The public is asked not to worry about the Covid-19 vaccine.

The head of the Indonesian Association of Experts on Epidemiology (PAEI), Hariadi Vibisono, has revealed that the vaccine against the coffin the government is working on is safe.

This is to prevent the spread of the Covid-19 virus in Indonesia.

“Over time, the study will be completed and the vaccine can be made.

“Later, we will go through POM (Food and Drug Administration) again to get a distribution permit.

“And the procedures that passed the review will be reviewed again.” Hariadi said in his statement, Thursday (5/10/2020).

Hariadi added that people should not worry too much about the safety level of vaccines, because according to Hariadi, the government has experience in dealing with vaccines.

“In my opinion, the concern should not be excessive.

“Because we are dealing with vaccines, in addition to vaccines, there are already many vaccines that have more or less the same procedure.
“There is a vaccine against hepatitis B, a vaccine for children, the procedure is the same.” he said.

Hariadi went on to say that before they were released to the public, the vaccines must have tested their level of safety. In addition, once used by the community, it will still be monitored for side effects that should not have occurred.

Healthcare workers inject vaccines into volunteers during clinical trial of Covid-19 vaccine candidate simulation at Pagan University of Medical Sciences, Bandung, West Java, Thursday (8.020.2020) The simulation was performed to handling and in phase III of the clinical testing of the production of vaccine candidates Covid-19 Sinovac of 1,620 volunteers.
Healthcare professionals inject vaccines into volunteers during a clinical trial of the vaccine candidate Covid-19 simulation at the Faculty of Medicine, Pajjaran University, Bandung, West Java, Thursday (February 8, 2020). The simulation was performed to see the readiness of the medical staff during handling and in phase III of the clinical trial of the production of vaccine candidates Covid-19 Sinovac for 1,620 volunteers. (BETWEEN PHOTOS / M AGUNG RAJASA)




Source link